Jeffrey S. Martini
At a glance: Jeffrey S. Martini is Chief Scientific Officer at Palvella Therapeutics (PVLA). Their latest SEC Form 4, filed Nov 12, 2026, reported a sale of $16K. On file: 0 purchase lines ($0) and 13 sale lines ($2.1M).
Chief Scientific Officer at Palvella Therapeutics, Inc. (PVLA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 1006,150 held (−2%) | $163.34 | $16K | -6.6% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 1,4494,701 held (−24%) | $164.85 | $239K | -7.5% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 1,6513,050 held (−35%) | $165.85 | $274K | -8.1% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 1,5001,550 held (−49%) | $166.91 | $250K | -8.6% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 2001,350 held (−13%) | $167.81 | $34K | -9.1% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 550800 held (−41%) | $169.03 | $93K | -9.8% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 800 | $172.12 | $138K | -11.4% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 1,6504,600 held (−26%) | $164.14 | $271K | -7.1% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 1,4673,133 held (−32%) | $165.78 | $243K | -8.0% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 1,1332,000 held (−36%) | $166.76 | $189K | -8.6% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 1,200800 held (−60%) | $167.75 | $201K | -9.1% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 600200 held (−75%) | $168.73 | $101K | -9.6% |
| Nov 12SEC | PVLAPalvella Therapeutics, Inc. | Sell Plan | 200 | $169.78 | $34K | -10.2% |
- Sell
Chief Scientific Officer Jeffrey S Martini sold $16K of PVLA at $163.34 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S Martini sold $239K of PVLA at $164.85 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S Martini sold $274K of PVLA at $165.85 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S Martini sold $250K of PVLA at $166.91 — cuts the stake by 49%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S Martini sold $34K of PVLA at $167.81 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jeffrey S Martini sold $93K of PVLA at $169.03 — cuts the stake by 41%; pre-scheduled 10b5-1 plan sale.
Follow Jeffrey S. Martini
Get one email when Jeffrey S. Martini files a new purchase or sale. Free.
At most one email a day about Jeffrey S. Martini, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.